Bone Graft and Substitutes Market Competitive Insights, Significant Futuristic Trends and Opportunities 2028 | Ace Surgical Supply Co., Inc., NovaBone Product, LLC., Exactech, Inc., Medtronic Plc.,

Rising prevalence of bone cancer to propel bone graft and substitutes market growth

Market Overview:

Bone grafting is a medical procedures in which replacement of missing bone is performed. Ceramics, polymers, and bioactive glass are some of the bone grafting solution.

Competitive Landscape:

Ace Surgical Supply Co., Inc., NovaBone Product, LLC., Exactech, Inc., Medtronic Plc., LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation., BioHorizons Implant Systems, Inc., Globus Medical, Inc., RTI Surgical, Inc., Geistlich Pharma, Megagen, Novadip Biosciences, Mesoblast Ltd., Alphatec Spine, Inc., Institut Straumann AG, NuVasive, Inc., OsteoMed LLC, KYERON Medical Innovations, ORTHOFIX INTERNATIONAL N.V., Johnson & Johnson, Bone Therapeutics SA, K2M Group Holdings, Inc., and OsteoNovus

To Get More Business Strategies Sample Copy of Report @ https://www.coherentmarketinsights.com/insight/request-sample/1050

Key Drivers

Growing prevalence of bone cancer to foster bone graft and substitutes market growth. For instance, according to 2017 American Society of Clinical Oncology (ASCO) estimates, around 3,450 people of all ages in the U.S. were diagnosed with primary bone cancer. Thus, new cases of bone cancer are expected to propel growth of the bone cancer treatment market in the U.S.

Advent of new product is also projected to accelerate growth of the market. For instance, in July 2021, Orthofix Medical Inc. announced the launch and first patient implants with the fiberFUSE™ Strip, an advanced demineralized fiber bone-graft solution containing cancellous bone

Covid-19 Impact Analysis

The market of bone grafts and substitutes has witnessed negative growth slope during covid-19 pandemic due to delay in non-emergency medical procedures.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables& Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-pdf/1050

Key Takeaways:

• The bone graft and substitutes market is expected to exhibit a CAGR of XX % over the forecast period owing to the growing prevalence of bone cancer.

• North America is expected to gain significant growth over the forecast period owing to the increasing focus of key players on developing advanced bone graft and substitutes.

• Increasing product launches by key players for expanding their portfolio of bone grafts is expected to drive the global bone graft and substitutes market growth. For instance, in May 2017, NovaBone Product, LLC launched two additional bone graft substitutes- NovaBone IRM and NovaBone IRM MacroPOR, that are designed for orthopedic application such as ontogenesis. Both products are expected to help in stimulation of osteoblastic activity and offer angiogenic potential.

Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/1050

About US:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This release was published on openPR.